ロード中...
5-ALA-guided resection of glioblastoma: a single-centre, retrospective analysis of progression pattern and survival
INTRODUCTION: The EORTC-NCIC trial in glioblastoma showed a median overall survival (OS) rate of 14.6 months following resection and chemoradiotherapy. This poor prognosis is attributed to early invasion and almost inevitable progression with failure to achieve local control. However, improvement in...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791633/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox238.085 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|